Categories AlphaGraphs, Earnings, Industrials

A visual dashboard of United Parcel Service (UPS) Q1 2020 earnings results

United Parcel Service’s (NYSE: UPS) bottom line for the first quarter of 2020 missed the market’s estimates, while the top line exceeded targets. UPS reported adjusted earnings of $1.15 per share on revenue of $18.04 billion compared to the analysts’ projected EPS of $1.23 and revenue of $17.21 billion. The company withdrew its previously issued 2020 revenue and EPS guidance as a result of the coronavirus pandemic impact.

United Parcel Service (UPS) Q1 2020 Earnings Infograph

UPS suspended its share buybacks for 2020, reducing its planned full-year repurchase target by approximately $783 million. The company paid the regular quarterly dividend of $1.01 per share to all outstanding Class A and Class B shareholders on March 10, 2020, to shareowners of record as of February 25, 2020.

On March 12, UPS named Carol Tome (the former CFO of The Home Depot and the board member of UPS) as CEO of the company effective June 1, 2020. Current CEO David Abney will become Executive Chairman of the Board with effect from June 1, 2020.

UPS stock, which plunged to a 52-week low ($17.80) last month, was trading up about 2% in the pre-market trading hours.

Also Read:  Take-Two Interactive Software (TTWO) Earnings: Key financials from Q1 2021

Most Popular

Baidu (BIDU) Q2 earnings rise unexpectedly; stock falls

https://www.youtube.com/watch?v=50yUaLybUnA&t=667s China-based internet search firm Baidu Inc. (NASDAQ: BIDU) reported financial results for the second quarter of 2020 on Thursday after the market's close. Earnings exceeded analysts’ expectations, but the

Applied Materials (AMAT) tops Q3 2020 targets; provides Q4 outlook

Applied Materials' (NASDAQ: AMAT) earnings and revenue for the third quarter exceeded the market's views. Adjusted EPS of $1.06 and revenue of $4.40 billion in Q3, grew 43% and 23%,

Is Altimmune (ALT) stock a buy right now?

A lot of stocks in the biotech space have skyrocketed this year after their announcements and advances in finding a vaccine or in the treatment of COVID-19. While these companies

Top